RegenMedTX Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

RegenMedTX General Information


Developer of cell therapies for chronic kidney disease. The company develops cell therapy products that are programmed in the body to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organ.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Corporate Office
  • 3929 Westpoint Boulevard
  • Suite G
  • Winston-Salem, NC 27103
  • United States
+1 (336) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RegenMedTX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Mar-2016 00.000 Completed Startup
1. Seed Round 05-Aug-2015 00.000 00.000 Completed Startup
To view RegenMedTX’s complete valuation and funding history, request access »

RegenMedTX Comparisons

HQ Location
Total Raised
Post Valuation
Developer of cell therapies for chronic kidney disease. The company develops cell therapy products that are programmed i
Winston-Salem, NC
000000&0 00.000


quat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolo
0000 000000000
Oslo, Norway
00 As of 0000


t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
Cambridge, MA
000 As of 0000
000000000 00 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RegenMedTX Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nextera Venture Capital-Backed Oslo, Norway 00 00000000000
Akebia Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000000 00 00000
Apellis Pharmaceuticals Formerly VC-backed Waltham, MA 000 00000 000000&0
You’re viewing 3 of 3 competitors. Get the full list »

RegenMedTX Patents

RegenMedTX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2010319385-A1 Rational design of regenerative medicine products Inactive 12-Nov-2009 00000000000
JP-2016187640-A Tissue engineering scaffolds Inactive 14-Feb-2008 00000000

RegenMedTX Executive Team (2)

Name Title Board Seat Contact Info
Deepak Jain Ph.D Chief Operating Officer
You’re viewing 1 of 2 executive team members. Get the full list »

RegenMedTX Board Members (3)

Name Representing Role Since
Kim Westmoreland Self Board Member 000 0000
William Hawkins III Self Chairman 000 0000
You’re viewing 2 of 3 board members. Get the full list »

RegenMedTX Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tengion 01-Nov-2017 000000000 Biotechnology
Tengion 06-Mar-2015 Merger/Acquisition 000.00 Biotechnology
To view RegenMedTX’s complete investments and acquisitions history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »